Abstract: A reflector including a substrate and a plurality of alternating layers of two materials having different indices of refraction disposed on the substrate, wherein the reflector exhibits a central peak in reflectance vs wavelength and the reflectance of the high-energy side-lobes is increased in intensity and the reflectance of the low-energy side-lobes is reduced in intensity and method for making the reflector is disclosed.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinson's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinson's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinson's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus,, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: Methods for determining the genetic predisposition of a human subject to developing renal disease, such as focal segmental glomerulosclerosis (FSGS) or end-stage kidney disease are provided herein. These methods include methods for detecting renal disease, or determining the risk of developing renal disease in a human subject, such as a subject of African ancestry. The methods utilize the detection of one or more haplotype blocks comprising at least two tag single nucleotide polymorphisms (SNPs) in a non-coding region of a MYH9 gene or detecting the presence of at least one tag SNP in a non-coding region of a MYH9 gene. An array for detecting a genetic predisposition to renal disease using probes complementary to the tag SNPs in the non-coding region of the MYH9 gene are also disclosed.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as RA, Tremors/Parkinson's Disease, and MS, and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from RA, MS, Tremors/Parkinson's Disease, and prostrate cancer realized immediate beneficial results with no side effects.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, Alzheimer's disease, ALS, Guillain-Barre syndrome, atherosclerosis, schizophrenia, Tremors/Parkinsons's disease, senile dementia, Muscular Dystrophy, Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Complex Regional Pain Syndrome, Diabetes, Neuropathic Pain, Spider Arthritis West Nile Virus, Fibromyalgia, Shingles, Gout, Migraine Headaches, Post Polio Syndrome, Central Virus Deafness, Asthma, Chronic Pain Of Unknown Origin and Hepatitis C and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostate cancer and others realized immediate beneficial results with no side effects.

Abstract: Methods for determining the genetic predisposition of a human subject to developing renal disease, such as focal segmental glomerulosclerosis (FSGS) or end-stage kidney disease are provided herein. These methods include methods for detecting renal disease, or determining the risk of developing renal disease in a human subject, such as a subject of African ancestry. The methods utilize the detection of one or more haplotype blocks comprising at least two tag single nucleotide polymorphisms (SNPs) in a non-coding region of a MYH9 gene or detecting the presence of at least one tag SNP in a non-coding region of a MYH9 gene. An array for detecting a genetic predisposition to renal disease using probes complementary to the tag SNPs in the non-coding region of the MYH9 gene are also disclosed.

Abstract: The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS, Tremors/Parkinson's Disease, and prostrate cancer realized immediate beneficial results with no side effects.

Abstract: A single, common correlation filter (CF) core is provided in a receiver for recovery of data from received code division multiple access (CDMA) signals. Signals are received over CDMA channels with different data rates, where the received signals include user information such as pilot and data symbols that have been spread according to different despreading rates including tier 1, tier 2 and tier 3 rates, where tier 1 is the smallest despreading rate. The received signal is correlated at the smallest despreading rate in the correlation filter (CF) by time multiplexing delayed versions of the pseudorandom noise (PN) code. The correlated information is then demultiplexed and pilot-aided QPSK demodulated. The demodulated information is summed at the proper integer multiple of the tier 1 rate to achieve tier 2 and tier 3 despreading rates. According to an embodiment, the three strongest multipaths components in terms of the received power are selected in a window or time period for optimal information recovery.

Abstract: A personal computer's (PC) microprocessor is used to provide both the physical layer (PHY) and media access control (MAC) processing functions required to implement a wireless local area network (WLAN) adapter. This technique uses the polling mechanism associated with the power save (PS) functionality of WLAN protocol to relieve networking stress on the host processing system. It does this while maintaining networking integrity and packet delivery. The WLAN protocol polling mechanism is used to briefly inhibit the transfer of packets from the WLAN access point (AP) during peak periods of network traffic and/or host processor loading. Because the modulation, demodulation, and MAC functions, typically implemented in dedicated hardware on existing adapters are implemented in software running on the host PC microprocessor, other host system processes and applications can interfere with these time critical functions.

Abstract: A method for setting a power level in a wireless communication system given directional setting of an antenna including the steps of determining a gain adjustment factor that depends upon the directional setting of an antenna, and applying the gain adjustment factor to control a power level of a transmitted signal.

Abstract: A Station Management Entity (SME) steers a directional antenna for a station to communicate with an Access Point (AP) in an 802.11 protocol system. The SME can steer the antenna before or after an 802.11 station has authenticated and associated with the Access Point. During a passive scan, the steering process cycles through the available antenna positions and monitors an AP beacon signal to determine a best position based on, for example, a Received Signal Strength Indication (RSSI). During an active scan where access probing is used, the steering process cycles through the antenna positions and monitors a probe response to determine the best antenna position. Additional scans may be performed based on a decision that the received signal level of the currently selected antenna position has dropped below a predetermined threshold.

Abstract: The present invention provides for making code rate adjustments and modulation type adjustments in a pseudonoise (PN) encoded CDMA system. Coding rate adjustments may be made by changing the number of information bits per symbol, or Forward Error Code (FEC) coding rate. A forward error correction (FEC) block size is maintained at a constant amount. Therefore, as the number of information bits per symbol are increased, an integer multiple of bits per epoch is always maintained. The scheme permits for a greater flexibility and selection of effective data rates providing information bit rates ranging from, for example, approximately 50 kilobits per second to over 5 mega bits per second (Mbps) in one preferred embodiment.

Abstract: A technique for steering a directional antenna such as may be used in a Wireless Local Area Network (WLAN) device. The technique detects signal parameters during reception of short sync pulses in the very beginning portion of a Packet Protocol Data Unit (PPDU) frame. As a result, the antenna can be steered to an optimum direction for reception prior to receiving other portions of a preamble that may be needed to acquire carrier signal phase and frequency.

Abstract: A system and method for encoding/decoding data channels in a CDMA system having data channel interference cancellation, wherein data channel interference cancellation is used to remove unwanted non-orthogonal pilot signal components which are present within a demodulated data signal. This is accomplished by regenerating interference terms with respect to the non-orthogonal pilot signal and subtracting them from the demodulated data signal.

Abstract: Individual RF cables span between element/transceiver pairs in traditional beam forming systems, and the number of elements in an array used for beam forming is thus restricted. To reduce the number of RF cables but maintain or increase the number of elements in an antenna array, an embodiment of the present invention includes electronics at the base of an antenna tower that apply digital multiplexing codes to signals communicated to electronics located at the top of the antenna tower. The electronics at the top demultiplex the signals and transmit them via the antenna array. Received RF signals are processed in a like manner in a reverse direction. Fewer transmission paths (e.g., RF or fiber optic cables) than the number of elements in the antenna array can be used. More antenna elements provide benefits, such as higher user capacity, more antenna beams, narrower antenna beams, and higher in-building penetration.

Abstract: Data rate allocation decisions are made for a communications channel, such as a wireless reverse link connection. A first parameter used in this determination is a path loss, which is determined by the following process. First, a message is sent from a first station to a second station, such as on a paging channel. The message indicates a forward Effective Radiated Power (ERP) of a pilot signal transmitted by the first station. The second station then determines the received signal strength of this pilot signal, taking into account receiver gains. The path loss can then be estimated by the second station as the difference between the forward ERP data value that it received and the detected received pilot power. The second station also then preferably determines a transmit power level when transmitting a message back to the first station. This transmit power level information is encoded as a digital data word together with the forward path loss information as calculated by the first station.

Abstract: The present invention provides for making code rate adjustments and modulation type adjustments in a pseudonoise (PN) encoded CDMA system. Coding rate adjustments may be made by changing the number of information bits per symbol, or Forward Error Code (FEC) coding rate. A forward error correction (FEC) block size is maintained at a constant amount. Therefore, as the number of information bits per symbol are increased, an integer multiple of bits per epoch is always maintained. The scheme permits for a greater flexibility and selection of effective data rates providing information bit rates ranging from, for example, approximately 50 kilobits per second to over 5 mega bits per second (Mbps) in one preferred embodiment.

Abstract: A system and method for encoding/decoding data channels in a CDMA system having data channel interference cancellation, wherein data channel interference cancellation is used to remove unwanted non-orthogonal pilot signal components which are present within a demodulated data signal. This is accomplished by regenerating interference terms with respect to the non-orthogonal pilot signal and subtracting them from the demodulated data signal.